VMP 8795211000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules
BNF code 0905013G0AABMBM
Virtual Therapeutic Moiety Magnesium glycerophosphate
Abbreviated name Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) caps
Basis of preferred name Other
Date of name applicability 16 Mar 2010
Previous name Magnesium glycerophosphate 48.6mg (magnesium 2mmol) capsules
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Magnesium glycerophosphate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 72717003
Strength value numerator 48.600
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Mag-4 (magnesium 48.6mg (2mmol)) capsules (Ennogen Healthcare Ltd)
MagnaPhos 48.6mg (2mmol) capsules (TriOn Pharma Ltd)
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules (Special Order)
MagnEss Gly 48.6mg (2mmol) capsules (Essential-Healthcare Ltd)
Virtual Medicinal Product Packs
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules 1 capsule
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules 30 capsule
Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules 50 capsule

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback